histamine antibodies
Biologicalexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Jul 1, 2017 (NCT03119766)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- HistamineImmunity, passive
immunity, passive - histamine
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- histamine antibodies
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03119766 | Phase 4 | Jul 1, 2017 | Materia Medica Holding |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Materia Medica Holding | For profit | 1 | 1 | 1 | 2017 |
1 organizations
Page 1 / 1